Truist analyst Youssef Squali raised the firm’s price target on Cimpress (CMPR) to $100 from $90 and keeps a Buy rating on the shares. The company’s Q2 results exceeded expectations, reflecting sustained demand for elevated, higher-value offerings with stabilization in the Y/Y decline in legacy products, the analyst tells investors in a research note.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CMPR: